Status:
COMPLETED
PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination
Lead Sponsor:
Bayer
Conditions:
Diagnostic Imaging
Eligibility:
All Genders
Brief Summary
The purpose of this study is to obtain data on the safety and efficacy of Ultravist application in usual daily use.The radiologist will administer the contrast medium to the patient as he/she would ha...
Eligibility Criteria
Inclusion
- Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist.
Exclusion
- No exclusion criteria besides the contraindications for the use of Ultravist as mentioned in the product information.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
44920 Patients enrolled
Trial Details
Trial ID
NCT00876083
Start Date
March 1 2008
End Date
September 1 2009
Last Update
February 28 2011
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Bosnia and Herzegovina
2
Many Locations, China
3
Many Locations, Germany
4
Many Locations, Hungary